The 4 CRP variants were chosen for their role in the innate immune system and availability in the SHS dataset, but no literature was found that examined CRP variants related to COVID-19 severity, perhaps because CRP has traditionally been viewed as a biomarker and not as a potential causal factor. This evidence concerns the gene CRP and COVID-19.